Sort
23,748 grants matching “melanoma”
Novel Approaches for Pancreatic Cancer Therapy
$363,788Columbia University Health Sciences · R01 · FY2005 · CA
Novel Approaches for Pancreatic Cancer Therapy
$363,788Columbia University Health Sciences · R01 · FY2003 · CA
MECHANISMS OF ANNEXIN A6-MEDIATED BASAL-LIKE BREAST CANCER PROGRESSION
$363,750Amos Malle Sakwe · Meharry Medical College · SC1 · FY2016 · CA
MECHANISMS OF ANNEXIN A6-MEDIATED BASAL-LIKE BREAST CANCER PROGRESSION
$363,750Amos Malle Sakwe · Meharry Medical College · SC1 · FY2019 · CA
MECHANISMS OF ANNEXIN A6-MEDIATED BASAL-LIKE BREAST CANCER PROGRESSION
$363,750Amos Malle Sakwe · Meharry Medical College · SC1 · FY2017 · CA
MECHANISMS OF ANNEXIN A6-MEDIATED BASAL-LIKE BREAST CANCER PROGRESSION
$363,750Amos Malle Sakwe · Meharry Medical College · SC1 · FY2018 · CA
Targeted Therapy for Head and Neck Cancer
$363,736Paul Hergenrother · University Of Illinois At Urbana-Champaign · R01 · FY2022 · DE
KALAMAZOO COMMUNITY CLINICAL ONCOLOGY PROGRAM
$363,725West Michigan Cancer Center · U10 · FY2000 · CA
Role of CPT1A as a lysine succinyltransferase in tumorigenesis
$363,713Taro Hitosugi · Mayo Clinic Rochester · R01 · FY2018 · CA
Role of CPT1A as a lysine succinyltransferase in tumorigenesis
$363,713Taro Hitosugi · Mayo Clinic Rochester · R01 · FY2021 · CA
The role of dietary copper in melanoma
$363,713Christopher M Counter · Duke University · R01 · FY2018 · CA
The role of dietary copper in melanoma
$363,713Christopher M Counter · Duke University · R01 · FY2016 · CA
The role of dietary copper in melanoma
$363,713Christopher M Counter · Duke University · R01 · FY2017 · CA
The role of dietary copper in melanoma
$363,713Christopher M Counter · Duke University · R01 · FY2015 · CA
Targeting Lymphatic Vessels for Ligand Directed Imaging
$363,713Renata Pasqualini · Rbhs -Cancer Institute Of New Jersey · R01 · FY2021 · CA
Targeting Lymphatic Vessels for Ligand Directed Imaging
$363,713Renata Pasqualini · Rbhs -Cancer Institute Of New Jersey · R01 · FY2020 · CA
Role of CPT1A as a lysine succinyltransferase in tumorigenesis
$363,713Taro Hitosugi · Mayo Clinic Rochester · R01 · FY2020 · CA
Optimizing Response to Immune Checkpoint Inhibitor Therapy for Breast Cancer: A Role for Inhibitors of the PI3K pathway
$363,453Ann Richmond · Vanderbilt University · R01 · FY2021 · CA
Expanding the Therapeutic Window of Nanoparticle STING Agonists for Cancer Immunotherapy
$363,450John Tanner Wilson · Vanderbilt University · R01 · FY2020 · CA
Generation of T-cell receptors recognizing antigens on non-melanoma tumors
$363,308James C Yang · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA
Project 2: The Impact of Immunotherapy on Human Vaccination
$363,288E. John Wherry · Massachusetts General Hospital · U19 · FY2022 · AI
EASTERN COOPERATIVE ONCOLOGY GROUP
$363,280Tufts Medical Center · U10 · FY2001 · CA
A mouse model for human gastrointestinal stromal tumor
$363,278Peter Besmer · Sloan-Kettering Inst Can Research · R01 · FY2014 · CA
Targeting the developmental pathways Notch and ERBB for melanoma therapy
$363,241Barbara Bedogni · Case Western Reserve University · R01 · FY2014 · CA
Defining the Role of the Cancer Circadian Clock in Tumor Immunity and Tumorigenesis
$363,222Chi V. Dang · Wistar Institute · R01 · FY2022 · CA